Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
DNA And Gene Chip Market Growth From $10.45 Billion In 2026 To $16.99 Billion By 2030 At A CAGR Of 12.9%
The dna and gene chip market has observed substantial growth over recent years. Its value is anticipated to rise from $9.2 billion in 2025 to $10.45 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.6%. This historical expansion can be ascribed to several factors, including the widening scope of genomic research activities, the increasing utilization of molecular diagnostics, the development of cancer research initiatives, the greater accessibility of advanced microarray platforms, and an increase in academic genomics funding.
The dna and gene chip market size is anticipated to experience substantial growth in the upcoming years. It is projected to reach $16.99 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.9%. This expansion throughout the forecast period stems from an intensified focus on personalized medicine, increasing investments in genomics-based drug discovery, the broadening of population-scale genetic screening, the rising adoption of AI-driven genomic analytics, and the expanding use of gene chips in agrigenomics. Prominent trends expected during this period include the increased embrace of high-density gene expression arrays, a rise in the application of single-cell analysis chips, an escalating demand for precision oncology diagnostics, the wider deployment of SNP and whole genome analysis chips, and a greater emphasis on high-throughput genomic screening.
Get A Free Sample Report With In-Depth Market Insights:
DNA And Gene Chip Market Demand Drivers: What’s Powering Industry Growth?
The growing imperative for early cancer diagnosis is a key driver for the expansion of the DNA and gene market. Cancer refers to a diverse set of diseases where abnormal cells proliferate uncontrollably in almost any organ or tissue, breaching normal boundaries to invade neighboring organs and metastasizing to other body areas. This heightened demand for early cancer detection is propelled by increasing public understanding of the benefits of identifying cancer at its initial stages, encouraging individuals to pursue timely screening, which in turn enhances treatment efficacy and survival rates. DNA and gene chips are employed to assess gene expression profiles, delineate the genetic and epigenetic makeup, and quantify genomic regulatory elements associated with cancer transcription factors in malignant cells. As an illustration, in May 2025, a report from the National Cancer Institute (NCI), a US-based federal government agency, predicted that the United States would experience approximately 2,041,910 new cancer cases and about 618,120 deaths from the illness in 2025. Therefore, the escalating requirement for early cancer detection is fostering the growth of the DNA and gene chip market.
DNA And Gene Chip Market Segment Breakdown: Which Categories Lead On Revenue?
The dna and gene chip market covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA)
2) By Application: Cancer Diagnostics, Gene Expression, Genomics, Drug Discovery, Agrigenomics
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
DNA And Gene Chip Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies within the DNA and gene chip market are creating innovative genotyping chips, such as Axiom YNS_Mol1, to advance the food industry and broaden insect consumption. Specifically, Axiom YNS_Mol1 is a genotyping chip designed for insect breeding, particularly focusing on the Tenebrio Molitor mealworm. For instance, in June 2023, Ÿnsect, a France-based company specializing in insect production, unveiled Axiom YNS_Mol1 as the world’s first genotyping chip for insect breeding. This groundbreaking genotyping chip was developed in partnership with Thermo Fisher Scientific, aiming to revolutionize insect breeding for sustainable food and pet food. The chip analyzes genetic characteristics, promoting genomic diversity and enhancing traits like growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This pioneering step is part of Ÿnsect’s ŸnFABRE project, contributing to the advancement of entomoculture and providing sustainable solutions in response to environmental challenges.
DNA And Gene Chip Market Top Companies Driving Competitive Growth
Major companies operating in the dna and gene chip market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., CapitalBio Corporation, Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation
View The Full DNA And Gene Chip Market Report:
DNA And Gene Chip Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the DNA and gene chip market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
